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httcense.Abstract Purpose: To evaluate multidetector CT (MDCT) signs of vascular invasion in pancre-
atic carcinoma.
Patients and methods: Retrospective review of preoperative dynamic MDCT of 42 patients with
pathologically proven pancreatic carcinoma.
Results: Surgically conﬁrmed invaded vessels were 19 arteries and 33 veins. Multiple signs of vas-
cular invasion were assessed.
Conclusion: Signiﬁcant advances have been made in the ability of MDCT to visualize pancreatic
cancer and to stage disease when close attention is paid to technique with special attention to multi-
ple signs of vascular invasion.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Primary prevention is the most effective approach to reduce
the incidence of pancreatic cancer because it is the fourth20 1207321719; Tel.: +20
oo.com (A. Shokry), omnia-
ayal@yahoo.com (A. Salah),
. Gomaa), amn_med09@ya-
tian Society of Radiology and
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p://dx.doi.org/10.1016/j.ejrnm.2013leading cause of cancer related death in the world with an
overall 5-year survival rate of less than 4% (1). Currently, sur-
gery remains the only option for cure (2).
The poor prognosis is usually due to late diagnosis (3). Exo-
crine tumors are the most common types of pancreatic cancer
with the adenocarcinoma representing about 90% of cases (4).
Surgical resection is the optimal curative treatment; how-
ever, only 20% of patients have resectable disease at diagnosis
(1,2,5,6).
Despite the advances of imaging, CT scan remains the main
imaging modality, although about 25–30% of patients who are
thought to have resectable lesions at CT have unresectable
lesions at surgery. There is no evidence of the optimal preop-
erative imaging modality for evaluation of patients with
suspected pancreatic cancer; however, assessment of vascular
invasion is an important issue for determining resectability
as resectability depends on the type of the vessel involvedgyptian Society of Radiology and Nuclear Medicine.
.03.006
Table 1 MDCT signs of involved arteries.
MDCT signs SMA CA HA Total
>50% Circumferential involvement 7 4 1 12
Vascular inﬁltration (wall irregularity) 2 1 1 4
Diameter stenosis 2 1 – 3
Vascular occlusion – – – –
SMA, superior mesenteric artery; CA, celiac artery; HA, hepatic
artery.
Table 2 MDCT signs of involved veins.
MDCT signs SMV PV Total
>50% circumferential involvement 8 2 10
Vascular inﬁltration (wall irregularity) 8 4 12
Diameter stenosis 7 2 9
Vascular occlusion 2 – 2
SMV, superior mesenteric vein; PV, portal vein.
Table 3 Number and percentages of MDCT signs in involved
arteries.
MDCT signs SMA CA HA Total %
Vascular contact 7/11 4/6 1/2 12/19 63.1
Vascular inﬁltration (wall irregularity) 2/11 1/6 1/2 4/19 21.1
Diameter stenosis 2/11 1/6 0/2 3/19 15.8
Vascular occlusion 0/11 0/6 0/2 0/19 0
SMA, superior mesenteric artery; CA, celiac artery; HA, hepatic
artery.
Table 4 Number and percentages of MDCT signs in involved
veins.
MDCT signs SMV PV Total %
>50% Vascular contact 8/21 2/4 10/33 30.3
Vascular inﬁltration (wall irregularity) 10/21 2/4 12/33 36.4
Diameter stenosis 7/21 2/4 9/33 27.3
Vascular occlusion 2/21 0/4 2/33 6
SMV, superior mesenteric vein; PV, portal vein.
Fig. 1 Number and percentages of MDCT signs in invaded
arteries and veins, (1) circumferential involvement (any degree for
arteries, >50% for veins), (2) vascular inﬁltration (wall irregu-
larity), (3) caliber stenosis and (4) vascular occlusion.
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tor CT (MDCT) allowed improvement in assessment of preop-
erative vascular invasion (7–9).
To our knowledge, previous studies stated variable negative
predictive values of MDCT in evaluating pancreatic carcinoma
with about 20–55% of patients incorrectly diagnosed as having
resectable tumor on CT and found to have unresectable tumor
at surgery. Most often, this type of misdiagnosis is due to
undetected vascular invasion (7,8).
The aim of this study was to evaluate MDCT signs of pre-
operative vascular invasion in pancreatic carcinoma.2. Patients and methods
2.1. Study population
A retrospective review of preoperative dynamic MDCT studies
of 42 patients (16 females and 26 males with ages ranging from
43 to 76 years, mean age 60.2 years) with pathologically pro-
ven pancreatic carcinoma who underwent operations (surgical
resection, exploration or surgical bypass) was done at National
Cancer Institute, Cairo University. Patients underwent surgi-
cal operations within 1–3 weeks after MDCT. No informed
consent was taken since it was a retrospective study, approved
by institutional ethics committee.
2.2. Imaging methods and MDCT imaging protocol
CT studies were performed by using a 64 MDCT scanner
(Light speed 64 slice VCT, GE Healthcare, Milwaukee, WI,
USA) before and after IV contrast medium administration.
The pre contrast series was taken by using a 5 mm slice
thickness.
The post contrast study was done using about 120–180 ml
of low osmolar non ionic contrast medium (iohexol, Omni-
paque 300; Amersham Health, Oslo, Norway) at a ﬂow rate
of 5 ml/s. The volume of contrast material was calculated
according to the body weight of the patient (2 ml of contrast
material per kilogram of body weight).
Patients received about 500 ml of water about 1 h prior to
scan and about 250 ml of additional water immediately before
scanning for better assessment of peripancreatic vascular struc-
tures, followed by IV injection of nonionic contrast medium
using a power injector.
MDCT scan was performed with the following acquisition
parameters: 200 mAs, 120 kVp, 512 · 512 matrix, 1.1 pitch,
64 · 0.625 mm collimation, 1 mm slice thickness, 0.6 mm
reconstruction increment.
Automated bolus tracking with bolus detection at the level
of the descending aorta above the diaphragm ensured accurate
timing of the data acquisition in the arterial phase.
Fig. 2 Pathologically proved pancreatic head carcinoma in 51 year old female, (A), (B), (C) portal phase and (D) pancreatic
parenchymal phase. The lesion showed <50% circumferential involvement of superior mesenteric vein (arrow), the case was resectable.
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chymal and hepatic portal phase was used.
Optimal scanning delay after triggering of bolus tracking at
50 H of aortic contrast enhancement was 5–10 s for the peri-
pancreatic arterial phase, 15–20 s for the pancreatic parenchy-
mal phase, and 45–55 s for the portal phase.
Multiplanar reformatted images were obtained at a post-
processing workstation.
2.3. Image analysis and interpretation
All CT images were analyzed and revised by three radiologists
with evaluation of 3 arteries (celiac, hepatic and superior mes-
enteric) and 2 veins (portal and superior mesenteric veins).
The degree of vascular involvement was estimated by cir-
cumferential vessel involvement by tumor. Circumferential
involvement was categorized as stage 1, less than one quarter
circumference of vessel contiguous with tumor; stage 2, be-
tween one quarter and one half of vessel circumference contig-
uous with tumor; stage 3, more than one half and up to three
quarters of vessel circumference contiguous with tumor; and
stage 4, more than three quarters of vessel circumference con-
tiguous with tumor. Stages 1 and 2 were considered resectable,
whereas grades 3 and 4 were considered unresectable. Border-
line resectable was used for cases of hard distinction between
resectable and unresectable.
Our patients were classiﬁed into resectable and borderline
resectable and unresectable.The criteria for unresectability and the degree of vascular
involvement, more than 50% circumferential vascular involve-
ment were used as a sign of invasion.
Criteria of unresectability included large tumors (more than
2 cm in size), presence of local or distant metastasis and vascu-
lar invasion of celiac trunk, hepatic artery, superior mesenteric
artery, portal vein or superior mesenteric vein.
We focused on vascular invasion in our study with the use
of degree of vascular involvement, more than 50% circumfer-
ential vascular involvement as a sign of invasion.
With recent advances in pancreatic imaging, the distinction
between resectable (stages I and II), locally advanced (stage
III) and unresectable (stage IV) disease may be quite hard
and the term ‘‘borderline resectable’’ is emerging to deﬁne
these tumors (10).
Borderline resectable tumors are deﬁned as those with tu-
mor abutment of <180 (<50%) of the SMA or celiac axis,
short segment abutment or encasement of the common hepatic
artery typically at the gastroduodenal artery origin, SMV-PV
abutment with impingement and narrowing or segmental ve-
nous occlusion with sufﬁcient venous ﬂow above and below
the occlusion to allow an option for venous reconstruction
(2,11).
Teardrop sign of superior mesenteric vein was considered as
a sign of unresectability (12).
Regarding isolated venous involvement, most surgeons do
not consider it as a contraindication for surgery as they per-
form partial venous resection with end-to-end anastomosis
or using bypass grafts (1).
Fig. 3 Pathologically proved pancreatic head carcinoma in 72 year old male, (A), (B), arterial phase, (C), (D) venous phase. The lesion
showed >50% circumferential involvement of superior mesenteric vein seen in venous phase images (arrow), the case was resectable. Two
non enhanced subcapsular bilomas were noted.
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– Vascular contact.
– Vessel wall irregularity (vascular inﬁltration).
– Diameter stenosis.
– Vascular occlusion.
2.4. Comparison with operative data and histologic examination
Results were conﬁrmed, compared and correlated with the
operative and pathologic results. Surgically conﬁrmed invaded
vessels were analyzed in detail.
2.5. Statistical analysis
Statistical calculations were performed using statistical soft-
ware (statistics program SPSS/PC).
Statistical tests were performed on signs of vascular inva-
sion to check for any signiﬁcant difference between the in-
vaded arteries and veins. P value of 0.05 was used to show
statistical signiﬁcance.3. Results
12 of 42 cases were surgically resectable and 30 cases were sur-
gically unresectable.
210 vessels were examined in all 42 cases (5 vessels in each
case). In the 30 unresectable cases, 52 vessels were invaded (in
many cases there were more than 1 vessel involved).
The involved vessels conﬁrmed at surgery were 52 (19 arter-
ies and 33 veins).
Occlusion was seen in 6% of involved veins and was not
seen in involved arteries. Circumferential vascular involvement
was seen in 63.1% of involved arteries compared to 30.3% of
involved veins. Vascular inﬁltration was seen in 21.1% of in-
volved arteries and in 36.4% of involved veins. Diameter ste-
nosis was seen in 15.8% of involved arteries compared to
27.3% of involved veins.
MDCT signs of involved arteries and veins respectively are
described in Tables 1 and 2, while statistical data for number
and percentages of MDCT signs in involved arteries and veins
respectively are shown in Tables 3 and 4. The number and per-
centages of different MDCT signs in invaded arteries and veins
are shown in Fig. 1, while Figs. 2–7 showed varieties of cases in
our study.
Fig. 4 Pathologically proved pancreatic head carcinoma in 60 year old male, (A), (B) arterial phase and (C) hepatic portal phase. The
lesion was encasing the hepatic artery which showed wall irregularity denoting vascular inﬁltration (arrow), the case was unresectable.
Fig. 5 Pathologically proved pancreatic head carcinoma in 62 year old female with signs of unresectability on dynamic MDCT study,
(A) arterial phase, (B), (C) pancreatic parenchymal phase and (D) portal venous phase. The lesion showed >50% circumferential
involvement of superior mesenteric artery and vein with thrombosed SMV and liver metastases, deﬁnite signs of unresectability.
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Fig. 6 Pathologically proved pancreatic head carcinoma located
in uncinate process in 60 year old male. The lesion was located
away from the vascular structures and diagnosed as resectable.
422 A. Shokry et al.12 of 42 cases (28.6%) were surgically resectable and 30
cases (71.4%) were surgically unresectable. All the 12 patients
diagnosed as resectable underwent surgical operations.
The overall accuracy of signs of vascular invasion was 75%.
Nine out of the 12 (75%) had successful tumor resection
with positive predictive value for resectability and accuracy
of 75%, while 3 (25%) patients had unresectable pancreatic tu-
mors (two patients showed invasion of superior mesenteric
vein and the third one showed involvement of superior mesen-
teric artery). The three patients underwent palliative
procedures.Fig. 7 Pathologically proved pancreatic body and tail carcinoma: 63
study, (A), (B) arterial phase, (C) hepatic portal phase and (D) reforma
celiac trunk and mesenteric vessels but was in contact with splenic a
resectable as involvement of splenic vessels does not preclude resectioThe patients that were believed to have resectable lesions on
the basis of MDCT were 3 out of 12 (25%) with the overall
accuracy of 75%. 9 patients (21.4% of all 42 patients) had suc-
cessful tumor resection.
4. Discussion
Pancreatic cancer is associated with a poor prognosis, and sur-
gical resection remains the only chance for curative therapy
(9).
In addition to assessing tumor contiguity with vessels, it
was found that changes in vessel diameter and vascular occlu-
sion are helpful signs for evaluation of vascular involvement.
MDCT is regarded as the most important non-invasive staging
technique in detecting vascular invasion (1).
It was found that the signs of arterial and venous involve-
ment are multiple, so it is necessary to evaluate MDCT signs
separately for arterial and venous involvement (1,3).
The major reason for the different CT signs of arterial and
venous invasion is that the venous wall is thinner and more
ﬂexible than the arterial wall, so when the vein is involved it
tends to be irregular and narrowed. For the same reason, ve-
nous occlusion is more common than arterial occlusion (13).
Regarding isolated venous involvement, most pancreatic
surgeons do not consider it as a contraindication for surgery
as they perform partial venous resection with end-to-end anas-
tomosis or using bypass grafts. Venous resections and recon-year old female with signs of vascular invasion on dynamic MDCT
tted coronal image for the arterial phase. The lesion was away from
rtery which showed focal caliber stenosis (arrow). The case was
n.
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ble and reliable, with morbidity and mortality similar to pan-
creaticoduodenectomy without vascular reconstruction (14).
Borderline resectable tumors are deﬁned as those with tu-
mor abutment of <180 (<50%) of the SMA or celiac axis,
short segment abutment or encasement of the common hepatic
artery typically at the gastroduodenal artery origin, SMV-PV
abutment with impingement and narrowing or segmental ve-
nous occlusion with sufﬁcient venous ﬂow above and below
the occlusion to allow an option for venous reconstruction.
Most of the patients who meet these CT criteria are candidates
for preoperative systemic chemotherapy followed by chemora-
diation since they are at a high risk for margin positive resec-
tion with upfront surgery (2).
In our study vascular occlusion was seen in 6% of involved
veins and was not seen in involved arteries. Circumferential
vascular contact was seen more in involved arteries (63.1%)
than in involved veins (30.3%). Vascular inﬁltration was seen
more in involved veins (36.4%) than in involved arteries
(21.1%). Diameter stenosis was seen in 15.8% of involved
arteries compared to 27.3% of involved veins.
The observations in this study have been supported by pre-
vious reports and published studies (1,9,12,13).
5. Conclusion
Signiﬁcant advances have been made in the ability of MDCT
to visualize pancreatic cancer and to stage disease when close
attention is paid to technique with special attention to multiple
signs of vascular invasion.
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